Company / Operating Margin
Verrica Pharmaceuticals Inc. Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-871.3%
FY2025
5-year range
-1283.4% / -235.8%
FY2021-FY2025
Trend
+32.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -235.8% to -871.3% over the past 2 years.
Based on SEC 10-K filings.
-871.3% in FY2025 with a 3-year CAGR of -613.7%.
Declined from -235.8% to -871.3% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -613.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 32.1% year-over-year.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -871.3% | +32.1% |
| FY2024 | -1283.4% | -444.3% |
| FY2023 | -235.8% | +8.5% |
| FY2022 | -257.6% | +23.1% |
| FY2021 | -334.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026